Acquisitions (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |
|---|---|---|---|
Sep. 17, 2026 |
Sep. 30, 2026 |
Sep. 30, 2026 |
|
| Asset Acquisition [Line Items] | |||
| Acquired In-Process Research and Development Expense | $ 111,000 | $ 111,000 | |
| Sangamo asset acquisition | |||
| Asset Acquisition [Line Items] | |||
| Payments to Acquire Productive Assets | $ 111,000 | ||
| Asset Acquisition, Consideration Transferred, Contingent Consideration | $ 100,000 |
| X | ||||||||||
- Definition The amount of expense recognized for the acquisition of in-process research and development assets that have no alternative future use. No definition available.
|
| X | ||||||||||
- Definition Amount of contingent consideration recognized as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|